no statement of use filed
on 01 May 2023
Last Applicant/ Owned by
One Amgen Center Drive
Thousand Oaks
CA
913201799
Serial Number
88628763 filed on 24th Sep 2019
Registration Number
N/A
Correspondent Address
Elsa D. Lemoine
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations and substances used for the treatment of bone, joint, intestine, colon, skin, lung, eye, bladder, blood cells, and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of autoimmune and immune system, inflammatory, inflammatory bowel, gastrointestinal, musculoskeletal, dermatological, pulmonary, respiratory, oncological, and Read More
Pharmaceutical preparations and substances used for the treatment of bone, joint, intestine, colon, skin, lung, eye, bladder, blood cells, and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of autoimmune and immune system, inflammatory, inflammatory bowel, gastrointestinal, musculoskeletal, dermatological, pulmonary, respiratory, oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances used for the treatment of arthritis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis, juvenile idiopathic arthritis, enthesitis related arthritis, osteoarthritis, peripheral spondyloarthritis, acute disc prolapse, inflammatory bowel disease, Crohn's disease, ulcerative colitis, Intestinal Behçet's Disease, chronic pouchitis, small bowel lesions, Hermansky-Pudlak syndrome, psoriasis, psoriasis vulgaris, psoriasis arthropica, plaque psoriasis, hidradenitis suppurativa, interstitial cystitis, sleep apnea, sarcoidosis, retinal vascular disorders, uveitis, choroidal neovascularization, Pyoderma Gangrenosum, giant cell arteritis, Netherton syndrome, anaplastic thyroid cancers, asthma, and refractory asthma
No 88628763
No Service/Collective Mark
No TM-1391-US-2
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 01st May 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 01st May 2023 | ABANDONMENT - NO USE STATEMENT FILED |
| 09th Sep 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 08th Sep 2022 | SOU EXTENSION 5 GRANTED |
| 08th Sep 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 29th Aug 2022 | SOU EXTENSION 5 FILED |
| 29th Aug 2022 | TEAS EXTENSION RECEIVED |
| 18th Feb 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 16th Feb 2022 | SOU EXTENSION 4 GRANTED |
| 16th Feb 2022 | SOU EXTENSION 4 FILED |
